國立虎尾科技大學 |

Genotoxicity and Carcinogenicity Testing of Pharmaceuticals

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Genotoxicity and Carcinogenicity Testing of Pharmaceuticals/ edited by Michael J. Graziano, David Jacobson-Kram.
other author:	Graziano, Michael J.
Description:	X, 206 p. 15 illus., 8 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Cancer research. -
Online resource:	https://doi.org/10.1007/978-3-319-22084-0
ISBN:	9783319220840

Genotoxicity and Carcinogenicity Testing of Pharmaceuticals
Genotoxicity and Carcinogenicity Testing of Pharmaceuticals[electronic resource] /edited by Michael J. Graziano, David Jacobson-Kram. - 1st ed. 2015. - X, 206 p. 15 illus., 8 illus. in color.online resource.

Introduction -- History and Current Regulatory Requirements -- Genotoxicity Testing of API and Impurities -- New Emerging Genotoxicity Tests -- Carcinogenicity Testing of Small Molecules -- Alternatives to the 2-Year Rodent Studies -- Addressing Positive Findings in Carcinogenicity Studies -- Investigating Tumor Signals in Clinical Trials -- Tumor Promoters -- Carcinogenicity Testing of Biologics -- In Silico Predictive Tests.

This book provides an overview of the nonclinical testing strategies that are used to asses and de-risk the genotoxicity and carcinogenicity properties of human pharmaceuticals. It includes a review of relevant ICH guidelines, numerous case studies where follow-up studies were conducted to further investigate positive findings, and practical considerations for the use of alternative and emerging tests. With contributions from recognized experts in the pharmaceutical industry and health authorities, this volume presents a balanced view on the interpretation and application of genotoxicity and carcinogenicity regulatory guidances. Genotoxicity and Carcinogenicity Testing of Pharmaceuticals is a valuable resource for scientists, regulators, and consultants that are engaged in the conduct, reporting, and review of nonclinical studies. This book will also help academicians better understand and appreciate the complexity of the regulations and breadth of toxicology research that are necessary to support the development and marketing of new drugs.

ISBN: 9783319220840

Standard No.: 10.1007/978-3-319-22084-0doiSubjects--Topical Terms:

1253664
Cancer research.

LC Class. No.: RC261-271

Dewey Class. No.: 614.5999

Genotoxicity and Carcinogenicity Testing of Pharmaceuticals
LDR:02846nam a22003855i 4500 001 961107
003 DE-He213
005 20200702113822.0
007 cr nn 008mamaa
008 201211s2015 gw | s |||| 0|eng d
020 $a 9783319220840 $9 978-3-319-22084-0
024 7 $a 10.1007/978-3-319-22084-0 $2 doi
035 $a 978-3-319-22084-0
050 4 $a RC261-271
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 614.5999 $2 23
245 1 0 $a Genotoxicity and Carcinogenicity Testing of Pharmaceuticals $h [electronic resource] / $c edited by Michael J. Graziano, David Jacobson-Kram.
250 $a 1st ed. 2015.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a X, 206 p. 15 illus., 8 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Introduction -- History and Current Regulatory Requirements -- Genotoxicity Testing of API and Impurities -- New Emerging Genotoxicity Tests -- Carcinogenicity Testing of Small Molecules -- Alternatives to the 2-Year Rodent Studies -- Addressing Positive Findings in Carcinogenicity Studies -- Investigating Tumor Signals in Clinical Trials -- Tumor Promoters -- Carcinogenicity Testing of Biologics -- In Silico Predictive Tests.
520 $a This book provides an overview of the nonclinical testing strategies that are used to asses and de-risk the genotoxicity and carcinogenicity properties of human pharmaceuticals. It includes a review of relevant ICH guidelines, numerous case studies where follow-up studies were conducted to further investigate positive findings, and practical considerations for the use of alternative and emerging tests. With contributions from recognized experts in the pharmaceutical industry and health authorities, this volume presents a balanced view on the interpretation and application of genotoxicity and carcinogenicity regulatory guidances. Genotoxicity and Carcinogenicity Testing of Pharmaceuticals is a valuable resource for scientists, regulators, and consultants that are engaged in the conduct, reporting, and review of nonclinical studies. This book will also help academicians better understand and appreciate the complexity of the regulations and breadth of toxicology research that are necessary to support the development and marketing of new drugs.
650 0 $a Cancer research. $3 1253664
650 0 $a Pharmaceutical technology. $3 557391
650 1 4 $a Cancer Research. $3 668358
650 2 4 $a Pharmaceutical Sciences/Technology. $3 768561
700 1 $a Graziano, Michael J. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1068915
700 1 $a Jacobson-Kram, David. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1068916
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319220833
776 0 8 $i Printed edition: $z 9783319220857
856 4 0 $u https://doi.org/10.1007/978-3-319-22084-0
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)